HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malcolm Spicer

Malcolm Spicer, Managing Editor – US

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.

Latest From Malcolm Spicer

US FDA Testing Finds Consumer Health Market Problems, But It Can’t Test Entire Marketplace

CDER compliance office director Donald Ashley offers a cautionary note to temper expectations for the FDA’s enforcement in the supplement sector. “We continue to warn the public about products very often sold as dietary supplements that contain hidden drugs,” he says.

Coronavirus COVID-19 FDA

Like COVID-19 Impact On Supply Chain, Expert Says Global Demand For Goods ‘Unprecedented’

UCLA professor Chris Tang says like most US businesses relying on supplies or production from outside the country, particularly from China, consumer health and beauty and personal care product companies should expect at least another year of supply disruption.

Coronavirus COVID-19 Consumer

US Herbal Supplement Sales Pass $10Bn For First Time In 2020 As Consumers Hunt Immunity Health

Report by American Botanical Council from research by Nutrition Business Journal and SPINS shows sales of supplements with herbal and/or fungal ingredients increased a record 17.3% from 2019, the segment's first double-digit growth in at least 20 years.

Dietary Supplements Market Intelligence

Royal DSM Fills Plate With Nutrition, Health And Bioscience, Plans To Slice Off Chemical Business

Sale is among options it’s considering for materials business, which is currently “managed largely on a standalone basis.” Its health, nutrition and bioscience segments account for 80% to 85% of total sales and will operate as individual business groups.

M & A Dietary Supplements

Herbalife Lowers Sales Growth Guidance On Eve Of Promoting Growth Drivers At Investor Day

Lowers Q3 net sales guidance to a decrease of 3.5% to 6.5% after previously forecasting a range between 5% growth and 1% decrease; for the year, it lowers previous estimate of 8.5% to 12.5% growth to net sales improving 4.5% to 8.5%.

Dietary Supplements Sales & Earnings

Measuring Consumer Exposure Confounds US FDA’s Evaluation Of Cannabinoid Safety In Supplements

Acting commissioner Woodcock reminds manufacturers and marketers that a consumer’s exposure to cannabidiol and other cannabinoids likely comes from using multiple products daily. “How do you control exposure of people in a nonprescription setting?”

Cannabidiol CBD FDA
See All
UsernamePublicRestriction

Register